Equities

Towa Pharmaceutical Co Ltd

Towa Pharmaceutical Co Ltd

Actions
  • Price (EUR)17.80
  • Today's Change-1.20 / -6.32%
  • Shares traded19.00
  • 1 Year change+10.56%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 15:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue227,934208,859165,615
OPERATING EXPENSES
Cost of revenue total146,551136,14595,429
Selling, general and admin. expenses, total50,49351,93439,492
Depreciation/amortization------
Unusual expense(income)(5307)2,340(2307)
Other operating expenses, total1.001.001.00
Total operating expense204,980205,685144,103
Operating income22,9543,17421,512
Other, net52890659
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes24,4594,60522,246
Provision for income taxes8,2862,4046,331
Net income after taxes16,1732,20115,915
Minority interest------
Net income before extra. Items16,1732,20115,915
Total extraordinary items------
Net income16,1732,20115,915
Inc.avail. to common excl. extra. Items16,1732,20115,914
Inc.avail. to common incl. extra. Items16,1732,20115,914
EPS RECONCILIATION
Basic/primary weighted average shares494949
Basic/primary eps excl. extra items32945323
Basic/primary eps incl. extra items32945323
Dilution adjustment----(2)
Diluted weighted average shares494950
Diluted eps excl. extra items32945316
Diluted eps incl. extra items32945316
COMMON STOCK DIVIDENDS
DPS - common stock primary issue606057
Gross dividend - common stock2,9522,9522,952
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental947635230
SUPPLEMENTAL INCOME
Depreciation, supplemental13,65914,26110,153
Total special items(1303)7,534(1602)
NORMALISED INCOME
Normalized income before taxes23,15612,13920,644
Effect of special items on income taxes(1874)1,246(684)
Income tax excluding impact of special items6,4123,6505,647
Normalized income after tax16,7448,48914,997
Normalized income avail. to common16,7448,48914,996
Basic normalized EPS340172305
Diluted normalized EPS340172298
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.